Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $12.13 Consensus Target Price from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have earned a consensus recommendation of “Buy” from the six research firms that are presently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $12.13.

A number of equities research analysts have recently weighed in on the stock. Canaccord Genuity Group dropped their price objective on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Oppenheimer lowered their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, October 21st.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX opened at $6.91 on Tuesday. Bioceres Crop Solutions has a fifty-two week low of $5.71 and a fifty-two week high of $14.05. The company has a market cap of $433.33 million, a PE ratio of 345.67 and a beta of 0.56. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27. The business has a 50-day simple moving average of $6.56 and a two-hundred day simple moving average of $8.32.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The company had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. During the same quarter last year, the business earned ($0.07) earnings per share. As a group, equities analysts expect that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Fourth Sail Capital LP raised its stake in shares of Bioceres Crop Solutions by 61.6% during the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock valued at $24,957,000 after buying an additional 1,209,277 shares during the last quarter. Long Focus Capital Management LLC grew its holdings in Bioceres Crop Solutions by 19.9% during the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock worth $3,145,000 after acquiring an additional 46,647 shares during the period. JPMorgan Chase & Co. raised its position in Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after acquiring an additional 29,693 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after acquiring an additional 5,341 shares during the period. Finally, Stifel Financial Corp boosted its position in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after purchasing an additional 10,224 shares in the last quarter. 17.68% of the stock is currently owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.